US Pharma MarketingThe post Another win for Lilly’s triple-g agonist in two more Phase III trials appeared first on Clinical Trials Arena.
Another win for Lilly’s triple-g agonist in two more Phase III trials
If approved, Lilly’s triple-g agonist would become the company’s fifth glucagon-based drug to be marketed. The post Another win for Lilly’s triple-g agonist in two more Phase III trials appeared first on Clinical Trials Arena .
If approved, Lilly’s triple-g agonist would become the company’s fifth glucagon-based drug to be marketed.
Source: Clinical Trials Arena